The National Pharmaceutical Pricing Authority (NPPA) has emphasized that the recent Goods and Services Tax (GST) rate cut is poised to benefit consumers across India by lowering the cost of essential medicines and healthcare products. The move, aimed at easing financial burdens on households, is expected to increase affordability and accessibility while stimulating demand in the pharmaceutical and healthcare sectors. NPPA notes that the reduction not only supports public health objectives but also enhances the competitiveness of domestic manufacturers.